Cargando…

Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]

Detalles Bibliográficos
Autores principales: Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407945/
https://www.ncbi.nlm.nih.gov/pubmed/37560051
http://dx.doi.org/10.1016/j.jve.2023.100340
_version_ 1785086076537274368
author Okumu, Eunice Akinyi
Henderson, Gail E.
Golin, Carol
Kuczynski, Kriste
Ormsby, Nuchanart Q.
Peay, Holly L.
author_facet Okumu, Eunice Akinyi
Henderson, Gail E.
Golin, Carol
Kuczynski, Kriste
Ormsby, Nuchanart Q.
Peay, Holly L.
author_sort Okumu, Eunice Akinyi
collection PubMed
description
format Online
Article
Text
id pubmed-10407945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104079452023-08-09 Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331] Okumu, Eunice Akinyi Henderson, Gail E. Golin, Carol Kuczynski, Kriste Ormsby, Nuchanart Q. Peay, Holly L. J Virus Erad Corrigendum Elsevier 2023-07-30 /pmc/articles/PMC10407945/ /pubmed/37560051 http://dx.doi.org/10.1016/j.jve.2023.100340 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Okumu, Eunice Akinyi
Henderson, Gail E.
Golin, Carol
Kuczynski, Kriste
Ormsby, Nuchanart Q.
Peay, Holly L.
Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title_full Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title_fullStr Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title_full_unstemmed Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title_short Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
title_sort corrigendum to “hiv remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [j virus erad 9 (2) (june 2023) 100331]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407945/
https://www.ncbi.nlm.nih.gov/pubmed/37560051
http://dx.doi.org/10.1016/j.jve.2023.100340
work_keys_str_mv AT okumueuniceakinyi corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331
AT hendersongaile corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331
AT golincarol corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331
AT kuczynskikriste corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331
AT ormsbynuchanartq corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331
AT peayhollyl corrigendumtohivremissiontrialinvestigatorsattitudestowardsriskandriskmitigationintrialsthatincludetreatmentinterruptionjviruserad92june2023100331